Chiu Harold Henrison C, Larrazabal Ramon B, Arcellana Anna Elvira S, Jimeno Cecilia A
Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Philippine General Hospital, University of the Philippines Manila.
Department of Medicine, Philippine General Hospital, University of the Philippines Manila.
Acta Med Philipp. 2023 Jul 27;57(7):31-37. doi: 10.47895/amp.vi0.4978. eCollection 2023.
Dyslipidemia in hypothyroidism results from the effects of thyroid hormones on lipid metabolism. These, in combination with hypothyroidism-induced hemodynamic changes, are risk factors for cardiometabolic diseases. We determined the prevalence of metabolic syndrome (MS) among adult Filipinos with hypothyroidism and compared clinical and laboratory characteristics of those with versus without MS.
This is a retrospective study of 105 patients with biochemically confirmed hypothyroidism. A review of records obtained anthropometric measurements, blood pressure, fasting blood glucose, lipid profile, and thyroid hormones. Clinical and laboratory characteristics were then compared between MS and those without. Significant differences were determined by two-way ANOVA, while heterogeneity of categorical variables was determined by chi-square or Fisher exact test. All data analyses were performed using Stata version 17.0 with a significance level of p<0.05.
The prevalence of MS is 36.19% (95%CI: 27.04%,46.15%). Body mass index (BMI) peaks at obese class I among those with MS. There is a significantly higher proportion of patients diagnosed to have diabetes (28.95% vs. 7.46%; p=0.003) and hypertension (52.63% vs. 14.93%; p<0.001) in the MS group. No significant differences were noted between groups regarding age, sex, etiology of hypothyroidism, blood pressure, fasting glucose, lipid profile, and thyroid hormone levels.
Our study showed that the prevalence of MS in adult Filipinos with hypothyroidism is increased at 36.19%. Only BMI, presence of diabetes, and hypertension were shown to be significantly higher. Emphasis must be placed on early screening among hypothyroid patients at high risk of developing MS. A prospective study using waist circumference and clinical and metabolic parameters is needed to validate these findings.
甲状腺功能减退症中的血脂异常是由甲状腺激素对脂质代谢的影响所致。这些因素与甲状腺功能减退症引起的血流动力学变化相结合,是心脏代谢疾病的危险因素。我们确定了成年菲律宾甲状腺功能减退症患者中代谢综合征(MS)的患病率,并比较了患有和未患有MS患者的临床和实验室特征。
这是一项对105例经生化确诊的甲状腺功能减退症患者的回顾性研究。通过查阅记录获取人体测量数据、血压、空腹血糖、血脂谱和甲状腺激素水平。然后比较MS患者和非MS患者的临床和实验室特征。采用双向方差分析确定显著差异,采用卡方检验或Fisher精确检验确定分类变量的异质性。所有数据分析均使用Stata 17.0版本进行,显著性水平为p<0.05。
MS的患病率为36.19%(95%CI:27.04%,46.15%)。MS患者的体重指数(BMI)在I级肥胖时达到峰值。MS组中被诊断患有糖尿病(28.95%对7.46%;p=0.003)和高血压(52.63%对14.93%;p<0.001)的患者比例显著更高。两组在年龄、性别、甲状腺功能减退症病因、血压、空腹血糖、血脂谱和甲状腺激素水平方面未发现显著差异。
我们的研究表明,成年菲律宾甲状腺功能减退症患者中MS的患病率增加至36.19%。仅BMI、糖尿病和高血压的患病率显著更高。必须重视对有发展为MS高风险的甲状腺功能减退症患者进行早期筛查。需要进行一项使用腰围以及临床和代谢参数的前瞻性研究来验证这些发现。